Camlin Fine Sciences Future Growth
Future criteria checks 4/6
Camlin Fine Sciences is forecast to grow earnings and revenue by 111.8% and 18.6% per annum respectively. EPS is expected to grow by 111.7% per annum. Return on equity is forecast to be 11.2% in 3 years.
Key information
111.8%
Earnings growth rate
111.7%
EPS growth rate
Chemicals earnings growth | 20.7% |
Revenue growth rate | 18.6% |
Future return on equity | 11.2% |
Analyst coverage | Low |
Last updated | 11 Feb 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 23,965 | 1,363 | 1,445 | N/A | 1 |
3/31/2025 | 21,786 | 984 | 459 | N/A | 1 |
3/31/2024 | 16,471 | -95 | -12,680 | N/A | 1 |
12/31/2023 | 16,381 | -8 | N/A | N/A | N/A |
9/30/2023 | 16,400 | 350 | 283 | 785 | N/A |
6/30/2023 | 17,174 | 674 | N/A | N/A | N/A |
3/31/2023 | 16,816 | 577 | -934 | 509 | N/A |
12/31/2022 | 16,441 | 581 | N/A | N/A | N/A |
9/30/2022 | 16,371 | 628 | -1,333 | 1,007 | N/A |
6/30/2022 | 14,650 | 442 | N/A | N/A | N/A |
3/31/2022 | 14,121 | 650 | -683 | 1,454 | N/A |
12/31/2021 | 13,495 | 598 | N/A | N/A | N/A |
9/30/2021 | 12,666 | 465 | -544 | 1,050 | N/A |
6/30/2021 | 12,122 | 579 | N/A | N/A | N/A |
3/31/2021 | 11,871 | 510 | 335 | 1,174 | N/A |
12/31/2020 | 11,533 | 394 | N/A | N/A | N/A |
9/30/2020 | 11,293 | 291 | 540 | 1,165 | N/A |
6/30/2020 | 10,948 | 302 | N/A | N/A | N/A |
3/31/2020 | 10,491 | 303 | -481 | 860 | N/A |
12/31/2019 | 10,243 | 349 | N/A | N/A | N/A |
9/30/2019 | 9,918 | 277 | -1,131 | 424 | N/A |
6/30/2019 | 9,709 | 221 | N/A | N/A | N/A |
3/31/2019 | 8,922 | 6 | -783 | -90 | N/A |
12/31/2018 | 8,523 | -139 | N/A | N/A | N/A |
9/30/2018 | 8,186 | -222 | N/A | N/A | N/A |
6/30/2018 | 7,634 | -277 | N/A | N/A | N/A |
3/31/2018 | 7,206 | -338 | -347 | -154 | N/A |
12/31/2017 | 6,403 | -367 | N/A | N/A | N/A |
9/30/2017 | 5,676 | -311 | N/A | N/A | N/A |
6/30/2017 | 5,347 | -275 | N/A | N/A | N/A |
3/31/2017 | 5,339 | -128 | N/A | -87 | N/A |
12/31/2016 | 5,149 | 98 | N/A | N/A | N/A |
9/30/2016 | 5,013 | 174 | N/A | N/A | N/A |
6/30/2016 | 5,063 | 232 | N/A | N/A | N/A |
3/31/2016 | 4,893 | 358 | N/A | 716 | N/A |
12/31/2015 | 5,083 | 445 | N/A | N/A | N/A |
9/30/2015 | 5,238 | 463 | N/A | N/A | N/A |
6/30/2015 | 5,531 | 552 | N/A | N/A | N/A |
3/31/2015 | 5,583 | 550 | N/A | 463 | N/A |
3/31/2014 | 5,087 | 287 | N/A | 267 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 532834 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (6.7%).
Earnings vs Market: 532834 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 532834 is expected to become profitable in the next 3 years.
Revenue vs Market: 532834's revenue (18.6% per year) is forecast to grow faster than the Indian market (10% per year).
High Growth Revenue: 532834's revenue (18.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 532834's Return on Equity is forecast to be low in 3 years time (11.2%).